Quantum techniques offer a glimpse of next-generation medicine Quantum-informed AI could open up unexplored chemical space, speeding the design of safer, more effective drugs.

https://www.drugdiscoverynews.com/quantum-techniques-offer-a-glimpse-of-next-generation-medicine-16815?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_4ohn1Rh86Av1dDd0FclJngmb4vJcSCDvwFCGHTDv0t2qqa-Y_7B2H0XhFnA5e4EIZfpZ9XwBpgMuvndjA3peWoJcEIw&_hsmi=411298769&utm_content=411298769&utm_source=hs_email Today, QSimulate, a biotech software company that develops quantum-informed simulation tools, announced a new round of financing that brings its total funding to over $11 million and simultaneously unveiled QUELO v2.3, the latest version of its quantum-enabled molecular simulation platform. The news signals that quantum mechanics is rapidly moving from a theoretical aspiration to a practical engine for pharmaceutical innovation. How multi-omics is redefining proteomics and precision discovery Transcriptomics, proteomics, and functional genomics are converging to create a new era of mechanism-aware drug discovery. https://www.drugdiscoverynews.com/how-multi-omics-is-redefining-proteomics-and-precision-discovery-16791?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_CI5s9FiP73vK25wn3IYJ_J-amkWWuiEZQDxecuNV7ldcj_YyNbuNA6ccYhDhkcRDZQWEDBTt8SHJzMDV17FLPf0SM2Q&_hsmi=411298769&utm_content=411298769&utm_source=hs_email After two decades dominated by genomics, the field’s attention has shifted toward understanding how genetic blueprints translate into functional, dynamic proteins — and how those proteins interact, fold, misfire, or evolve in the complex environment of living cells. Proteomics is now taking center stage and becoming the connective tissue that links the cell’s instructions to its outcomes.